SIDECE

Based in Guangzhou, China and founded in 2019, Guangzhou Side Medical Technology Co. , Ltd. , trading as SIDECE, is a medical device R&D and medical diagnostic service provider. The company's founder, Professor Liu Side, is a prominent gastroenterologist and head of the gastroenterology department at Nanfang Hospital.

The company has participated in key projects such as the Ministry of Industry and Information Technology's AI medical device innovation program and the Guangdong Province key research program. As of 2024, the company has been granted 51 patents and 3 software copyrights. In February 2026, SIDECE closed Series B+ funding from new investor Guangzhou Guoju Venture Capital. The company's main products include a mobile capsule gastroscopy system and an advanced AI image reading platform.

The company also operates a capsule endoscopy reading center, providing both in-house and third-party reading services and offers cloud-based remote diagnostic solutions for gastric disease screening and personal health management. The company generates revenue through the sale of its medical devices, image reading and diagnostic services and third-party screening and diagnostic solutions for healthcare institutions and individuals. The Series B+ funding raised in February 2026 will be used to accelerate product clinical validation, registration applications, and large-scale deployment in primary healthcare scenarios.